JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Inclusion Criteria:

• Adult age 21 and older

• Subjects with minimum of 2 year life expectancy

• Subjects have signed the informed consent document

• Subjects with unruptured infrarenal AAA who are assessed by the Investigator to beeligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices.

• Patient must be able and willing to comply with all required follow-up exams.

Exclusion Criteria:

• Currently participating in another trial where the primary endpoint has not beenreached yet.

• Known allergy to any of the device components

• Pregnant (females of childbearing potential only)

• Known connective tissue disorders

• Known active infection

• Subjects with pre-existing EVAR, i.e., in need of repair/intervention of apreviously failed EVAR.

• Patient has other medical, social, or psychological conditions that, in the opinionof the investigator, preclude them from receiving the pre-treatment, requiredtreatment, and post-treatment procedures and evaluations.